Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 14;25(30):4074-4091.
doi: 10.3748/wjg.v25.i30.4074.

Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases

Affiliations
Review

Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases

Matthew M Yeh et al. World J Gastroenterol. .

Abstract

Hepatocyte nuclear factor 4-alpha (HNF4α) is a highly conserved member of nuclear receptor superfamily of ligand-dependent transcription factors that is expressed in liver and gastrointestinal organs (pancreas, stomach, and intestine). In liver, HNF4α is best known for its role as a master regulator of liver-specific gene expression and essential for adult and fetal liver function. Dysregulation of HNF4α expression has been associated with many human diseases such as ulcerative colitis, colon cancer, maturity-onset diabetes of the young, liver cirrhosis, and hepatocellular carcinoma. However, the precise role of HNF4α in the etiology of these human pathogenesis is not well understood. Limited information is known about the role of HNF4α isoforms in liver and gastrointestinal disease progression. There is, therefore, a critical need to know how disruption of the expression of these isoforms may impact on disease progression and phenotypes. In this review, we will update our current understanding on the role of HNF4α in human liver and gastrointestinal diseases. We further provide additional information on possible use of HNF4α as a target for potential therapeutic approaches.

Keywords: Colorectal carcinoma; Gastrointestinal tract; Hepatocellular carcinoma; Hepatocyte nuclear factor 4-alpha; Liver cirrhosis; Transcription factor; Viral hepatitis.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: No potential conflicts of interest. No financial support.

Figures

Figure 1
Figure 1
Overview of regulatory and target genes involved in differentiated and de-differentiated stages of liver development. Examples of relevant HNF4α target genes identified by our group[27] are individually numbered.
Figure 2
Figure 2
Differentially expressed proteins in normal and liver disease states. Heat maps of differentially expressed proteins (DEPs) (truncated) that were selected following supervised analysis (A) Normal vs. Cirrhosis, (B) Normal vs. Hepatocellular carcinoma, (C) Cirrhosis vs. Hepatocellular carcinoma, and (D) Venn Diagram comparing the significantly DEPs identified. (E) Interactive Network Analysis of DEPs in cirrhosis and hepatocellular carcinoma as compared to normal shows HNF4α as a focus hub to many DEPs. (F) A representative of immunoblot analysis of TF and APOA1 (upper panel), HNF4α (lower panel) in tissue samples of AA & CA. GAPDH was used as a loading control, as published in[23].
Figure 3
Figure 3
Differential expression of hepatocyte nuclear factor 4alpha in cirrhotic and hepatocellular carcinoma livers. Representative H&E and P1/P2 HNF4α stained samples of HCV cirrhotic and hepatocellular carcinoma of Caucasian (A) and African American (B) tissue samples, as published in[27].
Figure 4
Figure 4
Immunoreactivity of hepatocyte nuclear factor 4alpha isoforms in cirrhotic and hepatocellular carcinoma livers. Data are presented as the mean ± standard error (n=4 tissue sections from 24 paraffin embedded tissue blocks). Data were evaluated for stastistical significance by one-way analysis of variance and are represented as follows: aP<0.05, bP<0.001as compared to normal for P1/P2 HNF4α (A) and P1- HNF4α (B). Black bar (CA) = Caucasian Americans; Gray bar (AA) = African Americans, as published in[27]

References

    1. Babeu JP, Boudreau F. Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks. World J Gastroenterol. 2014;20:22–30. - PMC - PubMed
    1. Chellappa K, Deol P, Evans JR, Vuong LM, Chen G, Briançon N, Bolotin E, Lytle C, Nair MG, Sladek FM. Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer. Elife. 2016;5 - PMC - PubMed
    1. Chen WS, Manova K, Weinstein DC, Duncan SA, Plump AS, Prezioso VR, Bachvarova RF, Darnell JE., Jr Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev. 1994;8:2466–2477. - PubMed
    1. Pentney RJ, Gratton A. Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study. Neuroscience. 1991;45:95–102. - PubMed
    1. Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, Kaestner KH, Rossi JM, Zaret KS, Duncan SA. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet. 2003;34:292–296. - PubMed

MeSH terms